DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Tutt A, Ellis P, Kilburn L et al.
The TNT trial: a randomized phase III trial of carboplatin(C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012). San Antonio Breast Cancer Symposium 2014; S3-01.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.